SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Credit Suisse X-Links Cushing® MLP Infrastructure ETN belonging to Credit Suisse Group AG (ADR)(NYSE:CS) will now adorn a Coupon given payment according to the report presented on August 16, 2016. Nonetheless, the “Current Yield” which equals the current quarterly Coupon Payment is not indicative of future quarterly Coupon Payments. The quarterly Coupon Payment has variability and dependency of the recent distributions of the MLPs the likes of index payments that hardly represent a fixed periodic interest payment.

Knowledgeable investors should only make the purchase of ETNs. They understand better the potential consequences of investing in the ETNs which are subjected to the credit risk of Credit Suisse. That means there are chances of receiving anything less than the principal amounts of your investment. At the same time, MLPs included in the index do not attract any partnership interests or other rights for investors. Seemingly, there are so many significant risks that involve investment in the ETNs.

Let’s learn about Credit Suisse AG

The world’s leading financial services provider offers a heightened level of expertise to its clients. Private banking, investment banking, and asset management are some of the areas that customers enjoy combined proficiency. The company which is part of the Credit Suisse group of companies has a whole list of other comprehensive solutions to institutional clients as well as innovative products for high-net-worth private clients. Its presence is in over 50 countries worldwide with a special mention of Switzerland where a majority of the retail clients are located.

The group which is headquartered in Zurich has an estimate of around 47,180 employees. Its shares are registered in the form of American Depositary Shares (CS), in New York. The group is now in waiting for approval of its registration having filed a statement with the Securities and Exchange Commission, or SEC. Nonetheless, it is possible to get more details from the Pricing Supplement as well as from the Prospectus Supplement dated May 4, 2015.